(Total Views: 449)
Posted On: 10/13/2025 8:27:48 AM
Post# of 157994
Add 2021 BTD to the mystery. Paperwork submitted -- if FDA approved it, still valid as BTD does not expire
2022 was alot of wild activity ---- did past mgt drop the follow-up on using a mTNBC BTD ??
BTD are usually @ Phase 2....right where we are on mTNBC
CytoDyn Submits Breakthrough Therapy Designation Application to FDA for Leronlimab as a Treatment for Metastatic Triple-Negative Breast Cancer (mTNBC);
Fast Track Designation for mTNBC was received previously.
November 8, 2021
2022 was alot of wild activity ---- did past mgt drop the follow-up on using a mTNBC BTD ??
BTD are usually @ Phase 2....right where we are on mTNBC
CytoDyn Submits Breakthrough Therapy Designation Application to FDA for Leronlimab as a Treatment for Metastatic Triple-Negative Breast Cancer (mTNBC);
Fast Track Designation for mTNBC was received previously.
November 8, 2021
(1)
(0)
